{
  "nodes": [
    {
      "label": "COMPANY",
      "name": "삼성바이오로직스",
      "properties": {
        "full_name": "Samsung Biologics",
        "industry": "Biotechnology",
        "headquarters": "Incheon, South Korea",
        "founded": "2011",
        "ceo": "John Rim"
      }
    },
    {
      "label": "COMPANY",
      "name": "셀트리온",
      "properties": {
        "full_name": "Celltrion",
        "industry": "Biotechnology",
        "headquarters": "Incheon, South Korea",
        "founded": "2002",
        "ceo": "Kee Woo-sung"
      }
    },
    {
      "label": "PERSON",
      "name": "도널드 트럼프",
      "properties": {
        "full_name": "Donald Trump",
        "role": "Former President of the United States",
        "nationality": "American",
        "age": "77"
      }
    },
    {
      "label": "PRODUCT",
      "name": "램시마",
      "properties": {
        "category": "Biosimilar",
        "description": "Infliximab biosimilar",
        "launch_date": "2013",
        "company": "셀트리온"
      }
    },
    {
      "label": "PRODUCT",
      "name": "트룩시마",
      "properties": {
        "category": "Biosimilar",
        "description": "Rituximab biosimilar",
        "launch_date": "2017",
        "company": "셀트리온"
      }
    },
    {
      "label": "PRODUCT",
      "name": "옴리클로",
      "properties": {
        "category": "Biosimilar",
        "description": "New biosimilar product",
        "launch_date": "2023",
        "company": "셀트리온"
      }
    },
    {
      "label": "PRODUCT",
      "name": "아이덴젤트",
      "properties": {
        "category": "Biosimilar",
        "description": "New biosimilar product",
        "launch_date": "2023",
        "company": "셀트리온"
      }
    },
    {
      "label": "EVENT",
      "name": "약가인하 행정명령 서명",
      "properties": {
        "date": "2023-10-12",
        "type": "Policy",
        "description": "Executive order signed by Donald Trump to reduce drug prices",
        "location": "United States"
      }
    }
  ],
  "relations": [
    {
      "start_node": "COMPANY",
      "relationship": "PRODUCES",
      "end_node": "PRODUCT",
      "properties": {}
    },
    {
      "start_node": "COMPANY",
      "relationship": "HEADQUARTERED_IN",
      "end_node": "LOCATION",
      "properties": {}
    },
    {
      "start_node": "COMPANY",
      "relationship": "COMPETES_WITH",
      "end_node": "COMPANY",
      "properties": {
        "market": "Biotechnology"
      }
    },
    {
      "start_node": "PERSON",
      "relationship": "SIGNED",
      "end_node": "EVENT",
      "properties": {}
    },
    {
      "start_node": "COMPANY",
      "relationship": "AFFECTED_BY",
      "end_node": "EVENT",
      "properties": {
        "impact": "Potential increase in biosimilar demand"
      }
    }
  ]
}